NDC 69543-268 - Virt-Phos 250 Neutral

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
69543-268
Package NDCs from labels
69543-268-10
Manufacturer
Virtus Pharmaceuticals
Effective date
2022-08-19
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Virt-Phos 250 Neutral - Virtus PharmaceuticalsVirtus Pharmaceuticals2022-08-19DIETARY SUPPLEMENT
Av-Phos 250 Neutral TabletsAvKARE, Inc.2016-04-11DIETARY SUPPLEMENT

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
69543-268-10EA - Each69543-26879df6060-26ec-4069-8f3a-6ccddc17ad2c12015-10-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
Potassium Phosphate, MonobasicACTIVE INGREDIENT4J9FJ0HL51VIRT-PHOS 250 NEUTRAL (SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE) TABLET [VIRTUS PHARMACEUTICALS]1
Sodium Phosphate, Dibasic, AnhydrousACTIVE INGREDIENT22ADO53M6FVIRT-PHOS 250 NEUTRAL (SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE) TABLET [VIRTUS PHARMACEUTICALS]1
Sodium Phosphate, Monobasic, MonohydrateACTIVE INGREDIENT593YOG76RNVIRT-PHOS 250 NEUTRAL (SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE) TABLET [VIRTUS PHARMACEUTICALS]1
Potassium CationACTIVE MOIETY295O53K152VIRT-PHOS 250 NEUTRAL (SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE) TABLET [VIRTUS PHARMACEUTICALS]1
Sodium CationACTIVE MOIETYLYR4M0NH37VIRT-PHOS 250 NEUTRAL (SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE) TABLET [VIRTUS PHARMACEUTICALS]1
Cellulose, MicrocrystallineINACTIVE INGREDIENTOP1R32D61UVIRT-PHOS 250 NEUTRAL (SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE) TABLET [VIRTUS PHARMACEUTICALS]1
Croscarmellose SodiumINACTIVE INGREDIENTM28OL1HH48VIRT-PHOS 250 NEUTRAL (SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE) TABLET [VIRTUS PHARMACEUTICALS]1
Magnesium StearateINACTIVE INGREDIENT70097M6I30VIRT-PHOS 250 NEUTRAL (SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE) TABLET [VIRTUS PHARMACEUTICALS]1
PolydextroseINACTIVE INGREDIENTVH2XOU12IEVIRT-PHOS 250 NEUTRAL (SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE) TABLET [VIRTUS PHARMACEUTICALS]1
Polyethylene Glycol 4000INACTIVE INGREDIENT4R4HFI6D95VIRT-PHOS 250 NEUTRAL (SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE) TABLET [VIRTUS PHARMACEUTICALS]1
Silicon DioxideINACTIVE INGREDIENTETJ7Z6XBU4VIRT-PHOS 250 NEUTRAL (SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE) TABLET [VIRTUS PHARMACEUTICALS]1
Stearic AcidINACTIVE INGREDIENT4ELV7Z65APVIRT-PHOS 250 NEUTRAL (SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE) TABLET [VIRTUS PHARMACEUTICALS]1
Titanium DioxideINACTIVE INGREDIENT15FIX9V2JPVIRT-PHOS 250 NEUTRAL (SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE) TABLET [VIRTUS PHARMACEUTICALS]1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 135 · 2,694 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
HERA SILKYSTAY FOUNDATION 49C1TITANIUM DIOXIDEAmorepacific Corporation5f4380d1-2cf4-1fd8-e063-6394a90a0aa32026-11-01WarningsExact identifier
unii: 15FIX9V2JP
HERA BLACK CUSHION FOUNDATION 13N1OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDEAmorepacific Corporation5aff3d25-d034-0815-e063-6294a90a86642026-10-29WarningsExact identifier
unii: 15FIX9V2JP
Blue Lizard Sensitive SPF 50 SunscreenTITANIUM DIOXIDE AND ZINC OXIDECrown Laboratories32d78048-d281-1d80-e063-6394a90aec192026-10-28WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 32W1TITANIUM DIOXIDEAmorepacific Corporation5eed2165-afc2-6958-e063-6294a90add582026-10-28WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 34O1TITANIUM DIOXIDEAmorepacific Corporation5eedd87b-a7b1-1abc-e063-6294a90ae29e2026-10-28WarningsExact identifier
unii: 15FIX9V2JP
URIMAR-T CAPSMETHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATEAllegis Pharmaceuticals, LLCcf7c3d65-11d2-49cd-b207-8ccc6a221fe02026-10-26Warnings, Adverse reactionsExact identifier
unii: 593YOG76RN
MB CAPSMETHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATEAllegis Pharmaceuticals, LLC2efeb281-b84b-4750-e063-6394a90a27ee2026-10-26Warnings, Adverse reactionsExact identifier
unii: 593YOG76RN
HERA SILKYSTAY FOUNDATION 26N1TITANIUM DIOXIDEAmorepacific Corporation5ec7151e-4f83-4aca-e063-6294a90a98182026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 26W1TITANIUM DIOXIDEAmorepacific Corporation5ec7276d-fcaf-65b2-e063-6394a90ac2202026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 28C1TITANIUM DIOXIDEAmorepacific Corporation5ec73566-5d67-7153-e063-6394a90aba332026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 28N1TITANIUM DIOXIDEAmorepacific Corporation5ec75100-153c-80cd-e063-6294a90a6d512026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 28O1TITANIUM DIOXIDEAmorepacific Corporation5ec77f7a-4621-ac0c-e063-6294a90a3f702026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 29N1TITANIUM DIOXIDEAmorepacific Corporation5ec7ab15-9cc1-d53a-e063-6294a90a41112026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 29W1TITANIUM DIOXIDEAmorepacific Corporation5ec83b87-08bc-7590-e063-6294a90a0b782026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 31C1TITANIUM DIOXIDEAmorepacific Corporation5ec857a3-7fd1-6461-e063-6394a90aacd72026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 31N1TITANIUM DIOXIDEAmorepacific Corporation5ec871dc-f74e-765c-e063-6394a90a27a52026-10-26WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 13N1TITANIUM DIOXIDEAmorepacific Corporation5eb19976-6983-3d9e-e063-6394a90a01ee2026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 17C2TITANIUM DIOXIDEAmorepacific Corporation5eb338c7-e99c-887d-e063-6394a90a977c2026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 17N1TITANIUM DIOXIDEAmorepacific Corporation5eb363fe-c2b2-9381-e063-6294a90ad0382026-10-25WarningsExact identifier
unii: 15FIX9V2JP
HERA SILKYSTAY FOUNDATION 17W1TITANIUM DIOXIDEAmorepacific Corporation5eb39387-7f6b-ce78-e063-6394a90a15ae2026-10-25WarningsExact identifier
unii: 15FIX9V2JP

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.